Novartis Corporate Responsibility News – Special Edition: Malaria
In this edition:
April was a very busy month for the global malaria community and for Novartis. We were active at the world’s largest malaria gathering, in Dakar, and later in London, at the Malaria Summit of the Commonwealth Heads of Government meeting – which ended with the inspiring commitment to halve the burden of malaria by 2023.
Top news, stories, opinion and commentary on key issues in corporate responsibility, including new agreements to fight NCDs in Uganda and Cameroon, the publication of our transparency report and a new malaria clinical trial.
Top news, stories, opinion and commentary on key issues in corporate responsibility, including a new agreement to fight NCDs, the launch of a new hypertension initiative and antibiotic innovation versus superbugs.